NIBIB in the News

Bioengineers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) are asking big questions—and striking up trans-NIH collaborations to answer them. And by joining forces with researchers across NIH’s intramural research program (IRP), they’re moving discovery into entirely new places. Read more at the NIH Catalyst.

This Associated Press interview with NIBIB Director Dr. Bruce Tromberg delves into COVID-19 infectiousness and COVID-19 antigen tests.

This article describes self-test reporting mechanisms used in the CDC-NIH Say Yes! COVID Test program. The pilot demonstrates that it is possible to establish an efficient and scalable electronic pathway for self-test result reporting to public health authorities.

The NIH recently invested over $74 million over five years to support 19 DS-I Africa awards that will conduct research and training activities across the continent.

How much should you trust the results of a rapid antigen test? That's a question many people are asking these days amid recent research and anecdotes suggesting these tests may be less sensitive to omicron. Researchers are working fast to figure out what's going on and how to improve the tests. Source: NPR.

With questions swirling about how well rapid COVID-19 tests work when it comes to detecting the omicron variant, leading scientists are now reassuring the public that they do work, and have a valuable role to play in the ongoing pandemic. Read more at ABC news online. ABC news online.

As the coronavirus spawns a record-breaking wave of infections, new research suggests that rapid tests widely used to identify potential covid-19 cases might be less effective at identifying illness caused by the swiftly spreading omicron variant. Read more at the Washington Post. Washington Post.

The U.S. drug regulator has granted emergency use authorization to German health technology company Siemens Healthineers' (SHLG.DE) at-home COVID-19 tests, a move that will boost availability of tests pressured by rising infection cases. Read more at Reuters. Reuters.

The US FDA said Tuesday that quick antigen tests people take at home may be less sensitive to picking up the Omicron variant of the coronavirus, but health officials say they're still a useful tool. Read more at CNN health. CNN health

Hari Shroff, NIBIB, answers questions about his latest research into confocal microscopy. Source: AZO Life Sciences.